Lilly invests in partnership to address non-communicable diseases
Eli Lilly and Company announced a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations. Lilly is launching The Lilly NCD Partnership, which combines the company’s unique resources with the expertise of leading global health organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people. The partnership will focus on diabetes and, over time, cancer
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
